Shortened leucocyte telomere length is associated independently with fibrosis stage in non-alcoholic fatty liver disease

Jing Zhang,S. Zang,Wenjun Yang,Yingji Chen,Z. Zhuang,Yan Luo,Gang Zhou,Baiyun,Zhao,Bing-yuan Wang,Junping Shi
2017-01-01
Abstract:This study aimed to assess the difference in leucocyte telomere length (LTL) between non-alcoholic fatty liver disease (NAFLD) patients and healthy controls. We measured LTL using a real-time PCR based method in 100 NAFLD patients and 100 healthy controls, and the relationship between short LTL and the risk and severity of the disease was examined using multivariate logistic regression analyses. We found mean LTL was significantly shorter in NAFLD patients than in controls (P < 0.001). Subjects with short LTL had a significantly elevated risk of NAFLD (OR: 3.095, 95% CI: 1.594-6.010; P = 0.001). Moreover, LTL was observed markedly shorter in NAFLD patients with fibrosis compared to patients with non-fibrosis (P = 0.010), multivariate logistic regression analysis indicated that short LTL was independently associated with a higher risk of severe fibrosis stage in NAFLD (OR: 10.799, 95% CI: 1.168-99.832, P = 0.036). Further analysis showed a linear correlation between LTL and the expression of hepatocyte senescent marker p21 (r = -0.413, P = 0.011). In conclusion, these results suggest that short LTL is closely associated with NAFLD and the severity of NAFLD fibrosis, and LTL has potential as a possible non-invasive prognosis biomarker for monitoring the severity of NAFLD fibrosis.
What problem does this paper attempt to address?